News
Introduction The outperformance of pharmaceutical company Eli Lilly and Company (LLY), due in large part to its diabetes and obesity franchise (Trulicity/dulaglutide and, more...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
News
Investment Thesis The past month has been tumultuous for electric utility companies in Florida as they raced against time to manage the aftermath of...
News
Dear readers/followers, At least one reader contacted me in conjunction with my last article on Eastman Kodak (NYSE:KODK) and specifically, that I held a...
News
On September 22nd, the management team at McDonald’s (NYSE:MCD) made a surprise announcement that, for the first time in 30 years, McDonald’s will raise...
News
The first big issue for a Medicare beneficiary is whether to enroll in original Medicare or a Medicare Advantage plan. The decision can be...
News
Dear readers/followers, Water Companies like American States Water (NYSE:AWR) are among the companies that unfortunately need to be repriced for this interest rate environment....
News
Last week, investors suffered a nasty surprise. Daily Shot The S&P (SP500) fell 3% in two days and the Nasdaq 3.5%. That’s the worst...
News
Shares of ConocoPhillips (NYSE:COP) have been on a strong run since July, alongside higher crude oil prices. Since I recommended buying shares last October,...
News
Introduction Houston-based Coterra Energy (CTRA) released its second quarter 2023 results on May 4, 2023. Note: I have followed CTRA quarterly since October 2017...
News
When Bristol Myers Squibb (NYSE:BMY) acquired Celgene for $74 billion dollars in November of 2019, it was a combination of two struggling companies each...
